Приказ основних података о документу

dc.creatorVidović, Bojana
dc.creatorĐorđević, Brižita
dc.creatorMilovanović, Srđan
dc.creatorSkrivanj, Sandra
dc.creatorPavlović, Zoran
dc.creatorStefanović, Aleksandra
dc.creatorKotur-Stevuljević, Jelena
dc.date.accessioned2019-09-02T11:33:57Z
dc.date.available2019-09-02T11:33:57Z
dc.date.issued2013
dc.identifier.issn0163-4984
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1906
dc.description.abstractThe aim of this study was to determine the plasma selenium (Se), copper (Cu), and zinc (Zn) levels and to evaluate their possible association with metabolic syndrome (MetS) components in patients with schizophrenia. The study group consisted of 60 patients with schizophrenia and 60 sex- and age-matched healthy controls. Anthropometric measurements, blood pressure, and biochemical analysis of fasting blood were performed in all subjects. Patients with schizophrenia had significantly higher plasma Cu concentrations compared with controls (0.97 +/- 0.31 vs. 0.77 +/- 0.32 mg/L, p = 0.001). The plasma Cu concentration showed a positive correlation with plasma glucose and diastolic blood pressure in the patient groups (r (s) = 0.263, p lt 0.05 and r (s) = 0.272, p lt 0.05, respectively). The plasma Se level correlated positive with MetS score (r (s) = 0.385, p lt 0.01), waist circumference (r (s) = 0.344, p lt 0.05), plasma glucose (r (s) = 0.319, p lt 0.05), and triglyceride concentrations (r (s) = 0.462, p lt 0.001) in patients with schizophrenia. Plasma Zn did not correlate with any of the MetS components. These results suggest that alterations in plasma Cu and Se levels in medicated patients with schizophrenia could be associated with metabolic risk factors.en
dc.publisherHumana Press Inc, Totowa
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/46001/RS//
dc.rightsrestrictedAccess
dc.sourceBiological Trace Element Research
dc.subjectSeleniumen
dc.subjectCopperen
dc.subjectZincen
dc.subjectMetabolic syndromeen
dc.subjectSchizophreniaen
dc.titleSelenium, Zinc, and Copper Plasma Levels in Patients with Schizophrenia: Relationship with Metabolic Risk Factorsen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractМиловановић, Срђан; Котур-Стевуљевић, Јелена; Ђорђевић, Брижита; Павловић, Зоран; Видовић, Бојана; Скривањ, Сандра; Стефановић, Aлександра;
dc.citation.volume156
dc.citation.issue1-3
dc.citation.spage22
dc.citation.epage28
dc.citation.other156(1-3): 22-28
dc.citation.rankM23
dc.identifier.wos000327897800004
dc.identifier.doi10.1007/s12011-013-9842-1
dc.identifier.pmid24150923
dc.identifier.scopus2-s2.0-84890803241
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу